|
|
|
Volumn 61, Issue 4, 1999, Pages 551-564
|
|
Promising anti-HIV therapeutic strategy with a small molecule CXCR4 antagonist.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE);
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CHEMOKINE RECEPTOR CXCR4;
HETEROCYCLIC COMPOUND;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
PHYSIOLOGY;
T LYMPHOCYTE;
VIROLOGY;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
HETEROCYCLIC COMPOUNDS;
HIV;
HIV INFECTIONS;
HUMANS;
RECEPTORS, CXCR4;
T-LYMPHOCYTES;
|
|
EID: 0032605844
PISSN: 03026469
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (8)
|
|
References (0)
|
